Advertisement

Index by author

February 01, 1992; Volume 260,Issue 2

A

  1. Ahlers, S T

    1. Antagonism studies with BMY-7378 and NAN-190: effects on 8-hydroxy-2-(di-n-propylamino)tetralin-induced increases in punished responding of pigeons.
      S T Ahlers, B A Weissman and J E Barrett
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 474-481;

  2. Albino-Teixeira, A

    1. Brief transient ischemia induces long-term depletion of norepinephrine without affecting the aromatic amino acid decarboxylase and monoamine oxidase activities in the rat kidney.
      P Soares-da-Silva, M H Fernandes, A Albino-Teixeira, I Azevedo and M Pestana
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 902-908;

  3. Ali, S F

    1. The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum.
      J F Bowyer, A W Tank, G D Newport, W Slikker, S F Ali and R R Holson
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 817-824;

  4. Allen, G T

    1. Interspecies differences in thromboxane receptors: studies with thromboxane receptor antagonists in rat and guinea pig smooth muscles.
      M L Ogletree and G T Allen
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 789-794;

  5. Allen, J

    1. Pharmacological characterization of in vivo [3H]lfenprodil binding sites in the mouse brain.
      J Benavides, B Peny, J Allen and B Scatton
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 896-901;

  6. Almeida, A R

    1. Time-dependent protective effects of calcium channel blockers on anoxia- and hypoxia-induced proximal tubule injury.
      A R Almeida, D Bunnachak, M Burnier, J F Wetzels, T J Burke and R W Schrier
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 526-532;

  7. Andersen, T T

    1. Acetylated endothelin-1 is a constrictor in guinea pig lung vasculature but not in isolated vascular strips.
      H I Magazine, A B Malik, C A Bruner and T T Andersen
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 632-636;

  8. Arreto, C D

    1. Thromboxane A2 accounts for bronchoconstriction but not for platelet sequestration and microvascular albumin exchanges induced by fMLP in the guinea pig lung.
      M F Bureau, F De Clerck, J Lefort, C D Arreto and B B Vargaftig
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 832-840;

  9. Au, J L

    1. Evidence of significant absorption of antipyrine from urinary bladder of rats.
      J T Dalton, M D Harrington and J L Au
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 608-613;

  10. Azevedo, I

    1. Brief transient ischemia induces long-term depletion of norepinephrine without affecting the aromatic amino acid decarboxylase and monoamine oxidase activities in the rat kidney.
      P Soares-da-Silva, M H Fernandes, A Albino-Teixeira, I Azevedo and M Pestana
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 902-908;

B

  1. Baba, H

    1. Mechanism of relaxation induced by K+ and nicotine in dog duodenal longitudinal muscle.
      N Toda, H Baba, Y Tanobe and T Okamura
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 697-701;

  2. Barnes, P J

    1. Endothelium-dependent nonadrenergic, noncholinergic neural relaxation in guinea pig pulmonary artery.
      S F Liu, D E Crawley, T W Evans and P J Barnes
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 541-548;

  3. Barrett, J E

    1. Antagonism studies with BMY-7378 and NAN-190: effects on 8-hydroxy-2-(di-n-propylamino)tetralin-induced increases in punished responding of pigeons.
      S T Ahlers, B A Weissman and J E Barrett
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 474-481;

  4. Beauchamp, D

    1. Age-dependent gentamicin experimental nephrotoxicity.
      D Beauchamp, P Gourde, G Thériault and M G Bergeron
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 444-449;

  5. Benavides, J

    1. Pharmacological characterization of in vivo [3H]lfenprodil binding sites in the mouse brain.
      J Benavides, B Peny, J Allen and B Scatton
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 896-901;

  6. Bendele, A M

    1. Pharmacologic evaluation of A23187-induced contractions of three distinct preparations of guinea pig lung parenchymal strips.
      W S Wong, A M Bendele and J H Fleisch
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 714-721;

  7. Bergeron, M G

    1. Age-dependent gentamicin experimental nephrotoxicity.
      D Beauchamp, P Gourde, G Thériault and M G Bergeron
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 444-449;

  8. Beutler, J J

    1. Comparative study of the effects of furosemide, ethacrynic acid and bumetanide on the lithium clearance and diluting segment reabsorption in humans.
      J J Beutler, W H Boer, H A Koomans and E J Dorhout Mees
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 768-772;

  9. Boer, W H

    1. Comparative study of the effects of furosemide, ethacrynic acid and bumetanide on the lithium clearance and diluting segment reabsorption in humans.
      J J Beutler, W H Boer, H A Koomans and E J Dorhout Mees
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 768-772;

  10. Bolden, C

    1. Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells.
      C Bolden, B Cusack and E Richelson
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 576-580;

  11. Bowen, W D

    1. Spinal opioid delta antinociception in the mouse: mediation by a 5'-NTII-sensitive delta receptor subtype.
      A Mattia, S C Farmer, A E Takemori, M Sultana, P S Portoghese, H I Mosberg, W D Bowen and F Porreca
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 518-525;

  12. Bowyer, J F

    1. The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum.
      J F Bowyer, A W Tank, G D Newport, W Slikker, S F Ali and R R Holson
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 817-824;

  13. Brändle, E

    1. Affinity of different local anesthetic drugs and catecholamines for the contraluminal transport system for organic cations in proximal tubules of rat kidneys.
      E Brändle, G Fritzsch and J Greven
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 734-741;

  14. Brink, C

    1. Histamine receptors on human isolated pulmonary arterial muscle preparations: effects of endothelial cell removal and nitric oxide inhibitors.
      J L Ortiz, C Labat, X Norel, I Gorenne, J Verley and C Brink
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 762-767;

  15. Brody, M J

    1. Coronary blood flow in rats is dependent on the release of vascular nitric oxide.
      L F Jones and M J Brody
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 627-631;

  16. Bruner, C A

    1. Acetylated endothelin-1 is a constrictor in guinea pig lung vasculature but not in isolated vascular strips.
      H I Magazine, A B Malik, C A Bruner and T T Andersen
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 632-636;

  17. Bryant, M S

    1. Hemoglobin adduct and hepatic- and urinary bladder-DNA adduct levels in rapid and slow acetylator Syrian inbred hamsters administered 2-aminofluorene.
      T J Flammang, T Yerokun, M S Bryant, L H Couch, W G Kirlin, K J Lee, F Ogolla, R J Ferguson, G Talaska and D W Hein
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 865-871;

  18. Buchholz, J

    1. Influence of age on control of norepinephrine release from the rat tail artery.
      J Buchholz, H Tsai, D Friedman and S P Duckles
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 722-727;

  19. Bunnachak, D

    1. Time-dependent protective effects of calcium channel blockers on anoxia- and hypoxia-induced proximal tubule injury.
      A R Almeida, D Bunnachak, M Burnier, J F Wetzels, T J Burke and R W Schrier
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 526-532;

  20. Bureau, M F

    1. Thromboxane A2 accounts for bronchoconstriction but not for platelet sequestration and microvascular albumin exchanges induced by fMLP in the guinea pig lung.
      M F Bureau, F De Clerck, J Lefort, C D Arreto and B B Vargaftig
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 832-840;

  21. Burger, R L

    1. Effects of fluoxetine on convulsions and on brain serotonin as detected by microdialysis in genetically epilepsy-prone rats.
      J W Dailey, Q S Yan, P K Mishra, R L Burger and P C Jobe
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 533-540;

  22. Burke, T J

    1. Time-dependent protective effects of calcium channel blockers on anoxia- and hypoxia-induced proximal tubule injury.
      A R Almeida, D Bunnachak, M Burnier, J F Wetzels, T J Burke and R W Schrier
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 526-532;

  23. Burnier, M

    1. Time-dependent protective effects of calcium channel blockers on anoxia- and hypoxia-induced proximal tubule injury.
      A R Almeida, D Bunnachak, M Burnier, J F Wetzels, T J Burke and R W Schrier
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 526-532;

  24. Butler, T W

    1. Neuroprotective effects of the N-methyl-D-aspartate receptor antagonists ifenprodil and SL-82,0715 on hippocampal cells in culture.
      I A Shalaby, B L Chenard, M A Prochniak and T W Butler
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 925-932;

C

  1. Carpenedo, F

    1. The catecholamine-mediated positive inotropic effect of simple quinones is related to superoxide anion generation.
      M Floreani and F Carpenedo
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 468-473;

  2. Castet, C

    1. Biochemical and pharmacological activities of SR 26831, a potent and selective elastase inhibitor.
      J M Herbert, D Frehel, M P Rosso, E Seban, C Castet, O Pepin, J P Maffrand and G Le Fur
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 809-816;

  3. Catto-Smith, A G

    1. A role for phospholipid-derived inflammatory mediators in intestinal anaphylaxis in the rat.
      W K MacNaughton, A G Catto-Smith and D G Gall
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 773-779;

  4. Chao, C C

    1. Chronic morphine administration impairs cell-mediated immune responses in swine.
      T W Molitor, A Morilla, J M Risdahl, M P Murtaugh, C C Chao and P K Peterson
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 581-586;

  5. Chenard, B L

    1. Neuroprotective effects of the N-methyl-D-aspartate receptor antagonists ifenprodil and SL-82,0715 on hippocampal cells in culture.
      I A Shalaby, B L Chenard, M A Prochniak and T W Butler
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 925-932;

  6. Chong, S

    1. Conversion of nitroglycerin to nitric oxide in microsomes of the bovine coronary artery smooth muscle is not primarily mediated by glutathione-S-transferases.
      S J Chung, S Chong, P Seth, C Y Jung and H L Fung
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 652-659;

  7. Chung, S J

    1. Conversion of nitroglycerin to nitric oxide in microsomes of the bovine coronary artery smooth muscle is not primarily mediated by glutathione-S-transferases.
      S J Chung, S Chong, P Seth, C Y Jung and H L Fung
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 652-659;

  8. Combs, M R

    1. Characterization of 5-hydroxytryptamine1B receptors in rat spinal cord via [125I]iodocyanopindolol binding and inhibition of [3H]-5-hydroxytryptamine release.
      I Matsumoto, M R Combs and D J Jones
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 614-626;

  9. Considine, R V

    1. Botulinum C2 toxin and steroid production in adrenal Y-1 cells: the role of microfilaments in the toxin-induced increase in steroid release.
      R V Considine, L L Simpson and J R Sherwin
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 859-864;

  10. Couch, L H

    1. Hemoglobin adduct and hepatic- and urinary bladder-DNA adduct levels in rapid and slow acetylator Syrian inbred hamsters administered 2-aminofluorene.
      T J Flammang, T Yerokun, M S Bryant, L H Couch, W G Kirlin, K J Lee, F Ogolla, R J Ferguson, G Talaska and D W Hein
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 865-871;

  11. Cox, B F

    1. Demonstration of vasorelaxant activity with an A1-selective adenosine agonist in porcine coronary artery: involvement of potassium channels.
      L A Merkel, R W Lappe, L M Rivera, B F Cox and M H Perrone
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 437-443;

  12. Crawley, D E

    1. Endothelium-dependent nonadrenergic, noncholinergic neural relaxation in guinea pig pulmonary artery.
      S F Liu, D E Crawley, T W Evans and P J Barnes
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 541-548;

  13. Cusack, B

    1. Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells.
      C Bolden, B Cusack and E Richelson
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 576-580;

D

  1. Dailey, J W

    1. Effects of fluoxetine on convulsions and on brain serotonin as detected by microdialysis in genetically epilepsy-prone rats.
      J W Dailey, Q S Yan, P K Mishra, R L Burger and P C Jobe
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 533-540;

  2. Dalton, J T

    1. Evidence of significant absorption of antipyrine from urinary bladder of rats.
      J T Dalton, M D Harrington and J L Au
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 608-613;

  3. Dauphin, F

    1. Identification of multiple muscarinic binding site subtypes in cat and human cerebral vasculature.
      F Dauphin and E Hamel
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 660-667;

  4. De Clerck, F

    1. Thromboxane A2 accounts for bronchoconstriction but not for platelet sequestration and microvascular albumin exchanges induced by fMLP in the guinea pig lung.
      M F Bureau, F De Clerck, J Lefort, C D Arreto and B B Vargaftig
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 832-840;

  5. Dorhout Mees, E J

    1. Comparative study of the effects of furosemide, ethacrynic acid and bumetanide on the lithium clearance and diluting segment reabsorption in humans.
      J J Beutler, W H Boer, H A Koomans and E J Dorhout Mees
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 768-772;

  6. Drewett, J G

    1. Neuromodulatory effects of atrial natriuretic peptides correlate with an inhibition of adenylate cyclase but not an activation of guanylate cyclase.
      J G Drewett, R J Ziegler and G J Trachte
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 689-696;

  7. Duckles, S P

    1. Complex prejunctional actions of the D2 dopamine agonists N-0923 and N-0924 in the rat tail artery.
      D J Friedman, D N Krause and S P Duckles
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 568-575;
    2. Influence of age on control of norepinephrine release from the rat tail artery.
      J Buchholz, H Tsai, D Friedman and S P Duckles
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 722-727;

E

  1. Eckman, D M

    1. Purinergic relaxation and hyperpolarization in guinea pig and rabbit coronary artery: role of the endothelium.
      K D Keef, J S Pasco and D M Eckman
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 592-600;

  2. Elhawary, A M

    1. Subtype-selective alpha-1 adrenoceptor alkylation in the rat kidney and its effect on the vascular pressor response.
      A M Elhawary, W A Pettinger and D W Wolff
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 709-713;

  3. Erhardt, J

    1. Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischemia-reperfusion.
      M R Siegfried, J Erhardt, T Rider, X L Ma and A M Lefer
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 668-675;

  4. Evans, T W

    1. Endothelium-dependent nonadrenergic, noncholinergic neural relaxation in guinea pig pulmonary artery.
      S F Liu, D E Crawley, T W Evans and P J Barnes
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 541-548;

F

  1. Farmer, S C

    1. Spinal opioid delta antinociception in the mouse: mediation by a 5'-NTII-sensitive delta receptor subtype.
      A Mattia, S C Farmer, A E Takemori, M Sultana, P S Portoghese, H I Mosberg, W D Bowen and F Porreca
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 518-525;

  2. Ferguson, R J

    1. Hemoglobin adduct and hepatic- and urinary bladder-DNA adduct levels in rapid and slow acetylator Syrian inbred hamsters administered 2-aminofluorene.
      T J Flammang, T Yerokun, M S Bryant, L H Couch, W G Kirlin, K J Lee, F Ogolla, R J Ferguson, G Talaska and D W Hein
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 865-871;

  3. Fernandes, M H

    1. Brief transient ischemia induces long-term depletion of norepinephrine without affecting the aromatic amino acid decarboxylase and monoamine oxidase activities in the rat kidney.
      P Soares-da-Silva, M H Fernandes, A Albino-Teixeira, I Azevedo and M Pestana
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 902-908;

  4. Fields, J Z

    1. Chronic ethanol feeding produces a muscarinic receptor upregulation, but not a muscarinic supersensitivity in lower esophageal sphincter muscle.
      A Keshavarzian, J H Gordon, C Willson, G Urban and J Z Fields
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 601-607;

  5. Flammang, T J

    1. Hemoglobin adduct and hepatic- and urinary bladder-DNA adduct levels in rapid and slow acetylator Syrian inbred hamsters administered 2-aminofluorene.
      T J Flammang, T Yerokun, M S Bryant, L H Couch, W G Kirlin, K J Lee, F Ogolla, R J Ferguson, G Talaska and D W Hein
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 865-871;

  6. Fleisch, J H

    1. Pharmacologic evaluation of A23187-induced contractions of three distinct preparations of guinea pig lung parenchymal strips.
      W S Wong, A M Bendele and J H Fleisch
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 714-721;

  7. Floreani, M

    1. The catecholamine-mediated positive inotropic effect of simple quinones is related to superoxide anion generation.
      M Floreani and F Carpenedo
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 468-473;

  8. Frehel, D

    1. Biochemical and pharmacological activities of SR 26831, a potent and selective elastase inhibitor.
      J M Herbert, D Frehel, M P Rosso, E Seban, C Castet, O Pepin, J P Maffrand and G Le Fur
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 809-816;

  9. Frey, B M

    1. Pharmacokinetics/pharmacodynamics of ketoconazole-prednisolone interaction.
      B Ulrich, F J Frey, R F Speck and B M Frey
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 487-490;

  10. Frey, F J

    1. Pharmacokinetics/pharmacodynamics of ketoconazole-prednisolone interaction.
      B Ulrich, F J Frey, R F Speck and B M Frey
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 487-490;

  11. Friedman, D

    1. Influence of age on control of norepinephrine release from the rat tail artery.
      J Buchholz, H Tsai, D Friedman and S P Duckles
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 722-727;

  12. Friedman, D J

    1. Complex prejunctional actions of the D2 dopamine agonists N-0923 and N-0924 in the rat tail artery.
      D J Friedman, D N Krause and S P Duckles
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 568-575;

  13. Fritzsch, G

    1. Affinity of different local anesthetic drugs and catecholamines for the contraluminal transport system for organic cations in proximal tubules of rat kidneys.
      E Brändle, G Fritzsch and J Greven
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 734-741;

  14. Fung, H L

    1. Conversion of nitroglycerin to nitric oxide in microsomes of the bovine coronary artery smooth muscle is not primarily mediated by glutathione-S-transferases.
      S J Chung, S Chong, P Seth, C Y Jung and H L Fung
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 652-659;

G

  1. Gaginella, T S

    1. Effect of endothelin-1 on guinea pig gallbladder smooth muscle in vitro.
      C Moummi, G W Gullikson and T S Gaginella
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 549-553;

  2. Gall, D G

    1. A role for phospholipid-derived inflammatory mediators in intestinal anaphylaxis in the rat.
      W K MacNaughton, A G Catto-Smith and D G Gall
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 773-779;

  3. Giles, R E

    1. Renal and antihypertensive effects of a novel eukalemic diuretic, ICI 207,828.
      S T Kau, B B Howe, P A Johnston, J H Li, T J Halterman, J S Zuzack, K Leszczynska, C L Yochim, J A Schwartz and R E Giles
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 450-457;

  4. Goda, Y

    1. Pharmacological characterization of 5-hydroxytryptamine-induced apnea in the rat.
      M Yoshioka, Y Goda, H Togashi, M Matsumoto and H Saito
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 917-924;

  5. Godai, K

    1. Reduced glomerular hypertrophy by somatostatin analog, SMS 201-995, in the subtotal nephrectomized rats fed high-protein meals.
      J Uemasu, K Godai, A Tokumoto and H Kawasaki
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 505-508;

  6. Gordon, J H

    1. Chronic ethanol feeding produces a muscarinic receptor upregulation, but not a muscarinic supersensitivity in lower esophageal sphincter muscle.
      A Keshavarzian, J H Gordon, C Willson, G Urban and J Z Fields
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 601-607;

  7. Gorenne, I

    1. Histamine receptors on human isolated pulmonary arterial muscle preparations: effects of endothelial cell removal and nitric oxide inhibitors.
      J L Ortiz, C Labat, X Norel, I Gorenne, J Verley and C Brink
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 762-767;

  8. Gourde, P

    1. Age-dependent gentamicin experimental nephrotoxicity.
      D Beauchamp, P Gourde, G Thériault and M G Bergeron
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 444-449;

  9. Granholm, A C

    1. Electrophysiological effects of ethanol on hippocampal and cerebellar neurons cografted with locus coeruleus in oculo: role of the noradrenergic circuitry.
      M R Palmer and A C Granholm
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 887-895;

  10. Gretler, D D

    1. 5-Hydroxytryptamine receptor activity of the dopamine receptor agonist fenoldopam in canine tracheal smooth muscle.
      D D Gretler, K C Jones and M B Murphy
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 491-498;

  11. Greven, J

    1. Affinity of different local anesthetic drugs and catecholamines for the contraluminal transport system for organic cations in proximal tubules of rat kidneys.
      E Brändle, G Fritzsch and J Greven
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 734-741;

  12. Gullikson, G W

    1. Effect of endothelin-1 on guinea pig gallbladder smooth muscle in vitro.
      C Moummi, G W Gullikson and T S Gaginella
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 549-553;

H

  1. Halterman, T J

    1. Renal and antihypertensive effects of a novel eukalemic diuretic, ICI 207,828.
      S T Kau, B B Howe, P A Johnston, J H Li, T J Halterman, J S Zuzack, K Leszczynska, C L Yochim, J A Schwartz and R E Giles
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 450-457;

  2. Hamel, E

    1. Identification of multiple muscarinic binding site subtypes in cat and human cerebral vasculature.
      F Dauphin and E Hamel
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 660-667;

  3. Hanano, M

    1. Effect of benzylpenicillin on the disposition of cefodizime in rats: no net effect on total clearance due to decreased hepatobiliary clearance and increased renal clearance.
      H Matsushita, H Suzuki, Y Sugiyama, Y Sawada, T Iga, Y Kawaguchi and M Hanano
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 499-504;

  4. Harlan, J T

    1. Genetic covariation in low alcohol-sensitive and high alcohol-sensitive selected lines of rats: behavioral and electrophysiological sensitivities to the depressant effects of ethanol and the development of acute neuronal tolerance to ethanol in situ at generation eight.
      M R Palmer, J T Harlan and K Spuhler
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 879-886;

  5. Harrington, M D

    1. Evidence of significant absorption of antipyrine from urinary bladder of rats.
      J T Dalton, M D Harrington and J L Au
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 608-613;

  6. Hasenkam, J M

    1. Calcium utilization coupled to stimulation of postjunctional alpha-1 and alpha-2 adrenoceptors in isolated human resistance arteries.
      H Nielsen, F V Mortensen, H K Pilegaard, J M Hasenkam and M J Mulvany
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 637-643;

  7. Hatfield, S M

    1. Cyclosporine and FK506 inhibition of murine mast cell cytokine production.
      S M Hatfield and N W Roehm
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 680-688;

  8. Hein, D W

    1. Hemoglobin adduct and hepatic- and urinary bladder-DNA adduct levels in rapid and slow acetylator Syrian inbred hamsters administered 2-aminofluorene.
      T J Flammang, T Yerokun, M S Bryant, L H Couch, W G Kirlin, K J Lee, F Ogolla, R J Ferguson, G Talaska and D W Hein
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 865-871;

  9. Herbert, J M

    1. Biochemical and pharmacological activities of SR 26831, a potent and selective elastase inhibitor.
      J M Herbert, D Frehel, M P Rosso, E Seban, C Castet, O Pepin, J P Maffrand and G Le Fur
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 809-816;

  10. Hoffman, B B

    1. Prolonged exposure to catecholamines enhances sensitivity of smooth muscle relaxation induced by sodium nitroprusside and atriopeptin.
      Z W Hu, K Honda, F Murad and B B Hoffman
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 756-761;

  11. Holson, R R

    1. The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum.
      J F Bowyer, A W Tank, G D Newport, W Slikker, S F Ali and R R Holson
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 817-824;

  12. Honda, K

    1. Prolonged exposure to catecholamines enhances sensitivity of smooth muscle relaxation induced by sodium nitroprusside and atriopeptin.
      Z W Hu, K Honda, F Murad and B B Hoffman
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 756-761;

  13. Honoré, T

    1. Relief of experimental spasticity and anxiolytic/anticonvulsant actions of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline.
      L Turski, P Jacobsen, T Honoré and D N Stephens
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 742-747;

  14. Hori, R

    1. H+ coupled active transport of bestatin via the dipeptide transport system in rabbit intestinal brush-border membranes.
      K Inui, Y Tomita, T Katsura, T Okano, M Takano and R Hori
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 482-486;

  15. Howe, B B

    1. Renal and antihypertensive effects of a novel eukalemic diuretic, ICI 207,828.
      S T Kau, B B Howe, P A Johnston, J H Li, T J Halterman, J S Zuzack, K Leszczynska, C L Yochim, J A Schwartz and R E Giles
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 450-457;

  16. Hu, Z W

    1. Prolonged exposure to catecholamines enhances sensitivity of smooth muscle relaxation induced by sodium nitroprusside and atriopeptin.
      Z W Hu, K Honda, F Murad and B B Hoffman
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 756-761;

  17. Hubner, C B

    1. Heroin, 6-acetylmorphine and morphine effects on threshold for rewarding and aversive brain stimulation.
      C B Hubner and C Kornetsky
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 562-567;

  18. Huhtaniemi, I

    1. Effect of chronic ethanol diet on expression of gonadotropin genes in the male rat.
      I Salonen, P Pakarinen and I Huhtaniemi
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 463-467;

  19. Huizinga, J D

    1. Involvement of nitric oxide in nerve-mediated inhibition and action of vasoactive intestinal peptide in colonic smooth muscle.
      J D Huizinga, J Tomlinson and J Pintin-Quezada
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 803-808;

  20. Humphreys, T M

    1. 5-HT2 receptor antagonists reverse amphetamine-induced slowing of dopaminergic neurons by interfering with stimulated dopamine synthesis.
      S M Sorensen, T M Humphreys, V L Taylor and C J Schmidt
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 872-878;

I

  1. Iga, T

    1. Effect of benzylpenicillin on the disposition of cefodizime in rats: no net effect on total clearance due to decreased hepatobiliary clearance and increased renal clearance.
      H Matsushita, H Suzuki, Y Sugiyama, Y Sawada, T Iga, Y Kawaguchi and M Hanano
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 499-504;

  2. Imura, Y

    1. Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents.
      Z Terashita, M Kawamura, M Takatani, S Tsushima, Y Imura and K Nishikawa
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 748-755;

  3. Inui, K

    1. H+ coupled active transport of bestatin via the dipeptide transport system in rabbit intestinal brush-border membranes.
      K Inui, Y Tomita, T Katsura, T Okano, M Takano and R Hori
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 482-486;

J

  1. Jacobsen, P

    1. Relief of experimental spasticity and anxiolytic/anticonvulsant actions of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline.
      L Turski, P Jacobsen, T Honoré and D N Stephens
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 742-747;

  2. Jobe, P C

    1. Effects of fluoxetine on convulsions and on brain serotonin as detected by microdialysis in genetically epilepsy-prone rats.
      J W Dailey, Q S Yan, P K Mishra, R L Burger and P C Jobe
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 533-540;

  3. Johnston, P A

    1. Renal and antihypertensive effects of a novel eukalemic diuretic, ICI 207,828.
      S T Kau, B B Howe, P A Johnston, J H Li, T J Halterman, J S Zuzack, K Leszczynska, C L Yochim, J A Schwartz and R E Giles
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 450-457;
    2. Evaluation of the renal site of action of a novel, eukalemic diuretic, ICI 207,828.
      P A Johnston and S T Kau
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 458-462;

  4. Jones, D J

    1. Characterization of 5-hydroxytryptamine1B receptors in rat spinal cord via [125I]iodocyanopindolol binding and inhibition of [3H]-5-hydroxytryptamine release.
      I Matsumoto, M R Combs and D J Jones
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 614-626;

  5. Jones, K C

    1. 5-Hydroxytryptamine receptor activity of the dopamine receptor agonist fenoldopam in canine tracheal smooth muscle.
      D D Gretler, K C Jones and M B Murphy
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 491-498;

  6. Jones, L F

    1. Coronary blood flow in rats is dependent on the release of vascular nitric oxide.
      L F Jones and M J Brody
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 627-631;

  7. Jung, C Y

    1. Conversion of nitroglycerin to nitric oxide in microsomes of the bovine coronary artery smooth muscle is not primarily mediated by glutathione-S-transferases.
      S J Chung, S Chong, P Seth, C Y Jung and H L Fung
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 652-659;

K

  1. Katsura, T

    1. H+ coupled active transport of bestatin via the dipeptide transport system in rabbit intestinal brush-border membranes.
      K Inui, Y Tomita, T Katsura, T Okano, M Takano and R Hori
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 482-486;

  2. Kau, S T

    1. Renal and antihypertensive effects of a novel eukalemic diuretic, ICI 207,828.
      S T Kau, B B Howe, P A Johnston, J H Li, T J Halterman, J S Zuzack, K Leszczynska, C L Yochim, J A Schwartz and R E Giles
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 450-457;
    2. Evaluation of the renal site of action of a novel, eukalemic diuretic, ICI 207,828.
      P A Johnston and S T Kau
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 458-462;

  3. Kawaguchi, Y

    1. Effect of benzylpenicillin on the disposition of cefodizime in rats: no net effect on total clearance due to decreased hepatobiliary clearance and increased renal clearance.
      H Matsushita, H Suzuki, Y Sugiyama, Y Sawada, T Iga, Y Kawaguchi and M Hanano
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 499-504;

  4. Kawamura, M

    1. Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents.
      Z Terashita, M Kawamura, M Takatani, S Tsushima, Y Imura and K Nishikawa
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 748-755;

  5. Kawasaki, H

    1. Reduced glomerular hypertrophy by somatostatin analog, SMS 201-995, in the subtotal nephrectomized rats fed high-protein meals.
      J Uemasu, K Godai, A Tokumoto and H Kawasaki
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 505-508;

  6. Keef, K D

    1. Purinergic relaxation and hyperpolarization in guinea pig and rabbit coronary artery: role of the endothelium.
      K D Keef, J S Pasco and D M Eckman
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 592-600;

  7. Keshavarzian, A

    1. Chronic ethanol feeding produces a muscarinic receptor upregulation, but not a muscarinic supersensitivity in lower esophageal sphincter muscle.
      A Keshavarzian, J H Gordon, C Willson, G Urban and J Z Fields
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 601-607;

  8. Kirlin, W G

    1. Hemoglobin adduct and hepatic- and urinary bladder-DNA adduct levels in rapid and slow acetylator Syrian inbred hamsters administered 2-aminofluorene.
      T J Flammang, T Yerokun, M S Bryant, L H Couch, W G Kirlin, K J Lee, F Ogolla, R J Ferguson, G Talaska and D W Hein
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 865-871;

  9. Koomans, H A

    1. Comparative study of the effects of furosemide, ethacrynic acid and bumetanide on the lithium clearance and diluting segment reabsorption in humans.
      J J Beutler, W H Boer, H A Koomans and E J Dorhout Mees
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 768-772;

  10. Kornetsky, C

    1. Heroin, 6-acetylmorphine and morphine effects on threshold for rewarding and aversive brain stimulation.
      C B Hubner and C Kornetsky
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 562-567;

  11. Krause, D N

    1. Complex prejunctional actions of the D2 dopamine agonists N-0923 and N-0924 in the rat tail artery.
      D J Friedman, D N Krause and S P Duckles
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 568-575;

L

  1. Labat, C

    1. Histamine receptors on human isolated pulmonary arterial muscle preparations: effects of endothelial cell removal and nitric oxide inhibitors.
      J L Ortiz, C Labat, X Norel, I Gorenne, J Verley and C Brink
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 762-767;

  2. Lappe, R W

    1. Demonstration of vasorelaxant activity with an A1-selective adenosine agonist in porcine coronary artery: involvement of potassium channels.
      L A Merkel, R W Lappe, L M Rivera, B F Cox and M H Perrone
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 437-443;

  3. Lee, K J

    1. Hemoglobin adduct and hepatic- and urinary bladder-DNA adduct levels in rapid and slow acetylator Syrian inbred hamsters administered 2-aminofluorene.
      T J Flammang, T Yerokun, M S Bryant, L H Couch, W G Kirlin, K J Lee, F Ogolla, R J Ferguson, G Talaska and D W Hein
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 865-871;

  4. Lee, T J

    1. Regional variation in acute vascular homologous tachyphylaxis.
      F J Miao and T J Lee
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 644-651;

  5. Lefer, A M

    1. Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischemia-reperfusion.
      M R Siegfried, J Erhardt, T Rider, X L Ma and A M Lefer
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 668-675;

  6. Lefort, J

    1. Thromboxane A2 accounts for bronchoconstriction but not for platelet sequestration and microvascular albumin exchanges induced by fMLP in the guinea pig lung.
      M F Bureau, F De Clerck, J Lefort, C D Arreto and B B Vargaftig
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 832-840;

  7. Le Fur, G

    1. Biochemical and pharmacological activities of SR 26831, a potent and selective elastase inhibitor.
      J M Herbert, D Frehel, M P Rosso, E Seban, C Castet, O Pepin, J P Maffrand and G Le Fur
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 809-816;

  8. Leszczynska, K

    1. Renal and antihypertensive effects of a novel eukalemic diuretic, ICI 207,828.
      S T Kau, B B Howe, P A Johnston, J H Li, T J Halterman, J S Zuzack, K Leszczynska, C L Yochim, J A Schwartz and R E Giles
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 450-457;

  9. Levine, W G

    1. Role of electronic factors in binding and reduction of azo dyes by hepatic microsomes.
      S Zbaida and W G Levine
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 554-561;

  10. Li, J H

    1. Renal and antihypertensive effects of a novel eukalemic diuretic, ICI 207,828.
      S T Kau, B B Howe, P A Johnston, J H Li, T J Halterman, J S Zuzack, K Leszczynska, C L Yochim, J A Schwartz and R E Giles
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 450-457;

  11. Liu, S F

    1. Endothelium-dependent nonadrenergic, noncholinergic neural relaxation in guinea pig pulmonary artery.
      S F Liu, D E Crawley, T W Evans and P J Barnes
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 541-548;

M

  1. Ma, X L

    1. Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischemia-reperfusion.
      M R Siegfried, J Erhardt, T Rider, X L Ma and A M Lefer
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 668-675;

  2. MacNaughton, W K

    1. A role for phospholipid-derived inflammatory mediators in intestinal anaphylaxis in the rat.
      W K MacNaughton, A G Catto-Smith and D G Gall
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 773-779;

  3. Maffrand, J P

    1. Biochemical and pharmacological activities of SR 26831, a potent and selective elastase inhibitor.
      J M Herbert, D Frehel, M P Rosso, E Seban, C Castet, O Pepin, J P Maffrand and G Le Fur
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 809-816;

  4. Magazine, H I

    1. Acetylated endothelin-1 is a constrictor in guinea pig lung vasculature but not in isolated vascular strips.
      H I Magazine, A B Malik, C A Bruner and T T Andersen
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 632-636;

  5. Maines, M D

    1. Tin-protoporphyrin: a potent inhibitor of hemoprotein-dependent steroidogenesis in rat adrenals and testes.
      M D Maines and G M Trakshel
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 909-916;

  6. Malik, A B

    1. Acetylated endothelin-1 is a constrictor in guinea pig lung vasculature but not in isolated vascular strips.
      H I Magazine, A B Malik, C A Bruner and T T Andersen
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 632-636;

  7. Malik, K U

    1. Prostaglandin synthesis elicited by adrenergic stimuli is mediated via alpha-2C and alpha-1A adrenergic receptors in cultured smooth muscle cells of rabbit aorta.
      C Nebigil and K U Malik
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 849-858;

  8. Matsuda, Y

    1. Pharmacological profile of HS-142-1, a novel nonpeptide atrial natriuretic peptide antagonist of microbial origin. I. Selective inhibition of the actions of natriuretic peptides in anesthetized rats.
      T Sano, Y Morishita, Y Matsuda and K Yamada
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 825-831;

  9. Matsumoto, I

    1. Characterization of 5-hydroxytryptamine1B receptors in rat spinal cord via [125I]iodocyanopindolol binding and inhibition of [3H]-5-hydroxytryptamine release.
      I Matsumoto, M R Combs and D J Jones
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 614-626;

  10. Matsumoto, M

    1. Pharmacological characterization of 5-hydroxytryptamine-induced apnea in the rat.
      M Yoshioka, Y Goda, H Togashi, M Matsumoto and H Saito
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 917-924;

  11. Matsushita, H

    1. Effect of benzylpenicillin on the disposition of cefodizime in rats: no net effect on total clearance due to decreased hepatobiliary clearance and increased renal clearance.
      H Matsushita, H Suzuki, Y Sugiyama, Y Sawada, T Iga, Y Kawaguchi and M Hanano
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 499-504;

  12. Mattia, A

    1. Spinal opioid delta antinociception in the mouse: mediation by a 5'-NTII-sensitive delta receptor subtype.
      A Mattia, S C Farmer, A E Takemori, M Sultana, P S Portoghese, H I Mosberg, W D Bowen and F Porreca
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 518-525;

  13. Merkel, L A

    1. Demonstration of vasorelaxant activity with an A1-selective adenosine agonist in porcine coronary artery: involvement of potassium channels.
      L A Merkel, R W Lappe, L M Rivera, B F Cox and M H Perrone
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 437-443;

  14. Miao, F J

    1. Regional variation in acute vascular homologous tachyphylaxis.
      F J Miao and T J Lee
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 644-651;

  15. Miller, A D

    1. Mechanisms of vomiting induced by serotonin-3 receptor agonists in the cat: effect of vagotomy, splanchnicectomy or area postrema lesion.
      A D Miller and S Nonaka
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 509-517;

  16. Mishra, P K

    1. Effects of fluoxetine on convulsions and on brain serotonin as detected by microdialysis in genetically epilepsy-prone rats.
      J W Dailey, Q S Yan, P K Mishra, R L Burger and P C Jobe
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 533-540;

  17. Molitor, T W

    1. Chronic morphine administration impairs cell-mediated immune responses in swine.
      T W Molitor, A Morilla, J M Risdahl, M P Murtaugh, C C Chao and P K Peterson
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 581-586;

  18. Morilla, A

    1. Chronic morphine administration impairs cell-mediated immune responses in swine.
      T W Molitor, A Morilla, J M Risdahl, M P Murtaugh, C C Chao and P K Peterson
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 581-586;

  19. Morishita, Y

    1. Pharmacological profile of HS-142-1, a novel nonpeptide atrial natriuretic peptide antagonist of microbial origin. I. Selective inhibition of the actions of natriuretic peptides in anesthetized rats.
      T Sano, Y Morishita, Y Matsuda and K Yamada
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 825-831;

  20. Mortensen, F V

    1. Calcium utilization coupled to stimulation of postjunctional alpha-1 and alpha-2 adrenoceptors in isolated human resistance arteries.
      H Nielsen, F V Mortensen, H K Pilegaard, J M Hasenkam and M J Mulvany
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 637-643;

  21. Mosberg, H I

    1. Spinal opioid delta antinociception in the mouse: mediation by a 5'-NTII-sensitive delta receptor subtype.
      A Mattia, S C Farmer, A E Takemori, M Sultana, P S Portoghese, H I Mosberg, W D Bowen and F Porreca
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 518-525;

  22. Moummi, C

    1. Effect of endothelin-1 on guinea pig gallbladder smooth muscle in vitro.
      C Moummi, G W Gullikson and T S Gaginella
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 549-553;

  23. Mulvany, M J

    1. Calcium utilization coupled to stimulation of postjunctional alpha-1 and alpha-2 adrenoceptors in isolated human resistance arteries.
      H Nielsen, F V Mortensen, H K Pilegaard, J M Hasenkam and M J Mulvany
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 637-643;

  24. Murad, F

    1. Prolonged exposure to catecholamines enhances sensitivity of smooth muscle relaxation induced by sodium nitroprusside and atriopeptin.
      Z W Hu, K Honda, F Murad and B B Hoffman
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 756-761;

  25. Murphy, M B

    1. 5-Hydroxytryptamine receptor activity of the dopamine receptor agonist fenoldopam in canine tracheal smooth muscle.
      D D Gretler, K C Jones and M B Murphy
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 491-498;

  26. Murtaugh, M P

    1. Chronic morphine administration impairs cell-mediated immune responses in swine.
      T W Molitor, A Morilla, J M Risdahl, M P Murtaugh, C C Chao and P K Peterson
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 581-586;

N

  1. Nebigil, C

    1. Prostaglandin synthesis elicited by adrenergic stimuli is mediated via alpha-2C and alpha-1A adrenergic receptors in cultured smooth muscle cells of rabbit aorta.
      C Nebigil and K U Malik
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 849-858;

  2. Newport, G D

    1. The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum.
      J F Bowyer, A W Tank, G D Newport, W Slikker, S F Ali and R R Holson
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 817-824;

  3. Nielsen, H

    1. Calcium utilization coupled to stimulation of postjunctional alpha-1 and alpha-2 adrenoceptors in isolated human resistance arteries.
      H Nielsen, F V Mortensen, H K Pilegaard, J M Hasenkam and M J Mulvany
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 637-643;

  4. Nishikawa, K

    1. Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents.
      Z Terashita, M Kawamura, M Takatani, S Tsushima, Y Imura and K Nishikawa
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 748-755;

  5. Noma, A

    1. Blockade of the ATP-sensitive K+ channel by 5-hydroxydecanoate in guinea pig ventricular myocytes.
      T Notsu, I Tanaka, M Takano and A Noma
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 702-708;

  6. Nonaka, S

    1. Mechanisms of vomiting induced by serotonin-3 receptor agonists in the cat: effect of vagotomy, splanchnicectomy or area postrema lesion.
      A D Miller and S Nonaka
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 509-517;

  7. Norel, X

    1. Histamine receptors on human isolated pulmonary arterial muscle preparations: effects of endothelial cell removal and nitric oxide inhibitors.
      J L Ortiz, C Labat, X Norel, I Gorenne, J Verley and C Brink
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 762-767;

  8. Notsu, T

    1. Blockade of the ATP-sensitive K+ channel by 5-hydroxydecanoate in guinea pig ventricular myocytes.
      T Notsu, I Tanaka, M Takano and A Noma
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 702-708;

O

  1. Ogletree, M L

    1. Interspecies differences in thromboxane receptors: studies with thromboxane receptor antagonists in rat and guinea pig smooth muscles.
      M L Ogletree and G T Allen
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 789-794;

  2. Ogolla, F

    1. Hemoglobin adduct and hepatic- and urinary bladder-DNA adduct levels in rapid and slow acetylator Syrian inbred hamsters administered 2-aminofluorene.
      T J Flammang, T Yerokun, M S Bryant, L H Couch, W G Kirlin, K J Lee, F Ogolla, R J Ferguson, G Talaska and D W Hein
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 865-871;

  3. Okamura, T

    1. Mechanism of relaxation induced by K+ and nicotine in dog duodenal longitudinal muscle.
      N Toda, H Baba, Y Tanobe and T Okamura
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 697-701;

  4. Okano, T

    1. H+ coupled active transport of bestatin via the dipeptide transport system in rabbit intestinal brush-border membranes.
      K Inui, Y Tomita, T Katsura, T Okano, M Takano and R Hori
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 482-486;

  5. Okuma, Y

    1. Release of endogenous noradrenaline from the vascularly perfused rat stomach in vitro: modulation by pre- and postsynaptic adrenoceptors.
      K Yokotani, Y Okuma and Y Osumi
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 728-733;

  6. Olsen, G D

    1. Cocaine and metabolite concentrations in the fetal guinea pig after chronic maternal cocaine administration.
      J A Sandberg and G D Olsen
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 587-591;

  7. Ortiz, J L

    1. Histamine receptors on human isolated pulmonary arterial muscle preparations: effects of endothelial cell removal and nitric oxide inhibitors.
      J L Ortiz, C Labat, X Norel, I Gorenne, J Verley and C Brink
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 762-767;

  8. Osumi, Y

    1. Release of endogenous noradrenaline from the vascularly perfused rat stomach in vitro: modulation by pre- and postsynaptic adrenoceptors.
      K Yokotani, Y Okuma and Y Osumi
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 728-733;

P

  1. Pakarinen, P

    1. Effect of chronic ethanol diet on expression of gonadotropin genes in the male rat.
      I Salonen, P Pakarinen and I Huhtaniemi
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 463-467;

  2. Palmer, M R

    1. Genetic covariation in low alcohol-sensitive and high alcohol-sensitive selected lines of rats: behavioral and electrophysiological sensitivities to the depressant effects of ethanol and the development of acute neuronal tolerance to ethanol in situ at generation eight.
      M R Palmer, J T Harlan and K Spuhler
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 879-886;
    2. Electrophysiological effects of ethanol on hippocampal and cerebellar neurons cografted with locus coeruleus in oculo: role of the noradrenergic circuitry.
      M R Palmer and A C Granholm
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 887-895;

  3. Pasco, J S

    1. Purinergic relaxation and hyperpolarization in guinea pig and rabbit coronary artery: role of the endothelium.
      K D Keef, J S Pasco and D M Eckman
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 592-600;

  4. Peny, B

    1. Pharmacological characterization of in vivo [3H]lfenprodil binding sites in the mouse brain.
      J Benavides, B Peny, J Allen and B Scatton
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 896-901;

  5. Pepin, O

    1. Biochemical and pharmacological activities of SR 26831, a potent and selective elastase inhibitor.
      J M Herbert, D Frehel, M P Rosso, E Seban, C Castet, O Pepin, J P Maffrand and G Le Fur
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 809-816;

  6. Perrone, M H

    1. Demonstration of vasorelaxant activity with an A1-selective adenosine agonist in porcine coronary artery: involvement of potassium channels.
      L A Merkel, R W Lappe, L M Rivera, B F Cox and M H Perrone
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 437-443;

  7. Pestana, M

    1. Brief transient ischemia induces long-term depletion of norepinephrine without affecting the aromatic amino acid decarboxylase and monoamine oxidase activities in the rat kidney.
      P Soares-da-Silva, M H Fernandes, A Albino-Teixeira, I Azevedo and M Pestana
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 902-908;

  8. Peterson, P K

    1. Chronic morphine administration impairs cell-mediated immune responses in swine.
      T W Molitor, A Morilla, J M Risdahl, M P Murtaugh, C C Chao and P K Peterson
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 581-586;

  9. Pettinger, W A

    1. Subtype-selective alpha-1 adrenoceptor alkylation in the rat kidney and its effect on the vascular pressor response.
      A M Elhawary, W A Pettinger and D W Wolff
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 709-713;

  10. Pilegaard, H K

    1. Calcium utilization coupled to stimulation of postjunctional alpha-1 and alpha-2 adrenoceptors in isolated human resistance arteries.
      H Nielsen, F V Mortensen, H K Pilegaard, J M Hasenkam and M J Mulvany
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 637-643;

  11. Pintin-Quezada, J

    1. Involvement of nitric oxide in nerve-mediated inhibition and action of vasoactive intestinal peptide in colonic smooth muscle.
      J D Huizinga, J Tomlinson and J Pintin-Quezada
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 803-808;

  12. Porreca, F

    1. Spinal opioid delta antinociception in the mouse: mediation by a 5'-NTII-sensitive delta receptor subtype.
      A Mattia, S C Farmer, A E Takemori, M Sultana, P S Portoghese, H I Mosberg, W D Bowen and F Porreca
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 518-525;

  13. Portoghese, P S

    1. Spinal opioid delta antinociception in the mouse: mediation by a 5'-NTII-sensitive delta receptor subtype.
      A Mattia, S C Farmer, A E Takemori, M Sultana, P S Portoghese, H I Mosberg, W D Bowen and F Porreca
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 518-525;

  14. Prochniak, M A

    1. Neuroprotective effects of the N-methyl-D-aspartate receptor antagonists ifenprodil and SL-82,0715 on hippocampal cells in culture.
      I A Shalaby, B L Chenard, M A Prochniak and T W Butler
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 925-932;

R

  1. Ramwell, P W

    1. Interaction of non-arginine compounds with the endothelium-derived relaxing factor inhibitor, NG-monomethyl L-arginine.
      G Thomas and P W Ramwell
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 676-679;

  2. Raynor, K

    1. Differential coupling of somatostatin1 receptors to adenylyl cyclase in the rat striatum vs. the pituitary and other regions of the rat brain.
      K Raynor and T Reisine
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 841-848;

  3. Reisine, T

    1. Differential coupling of somatostatin1 receptors to adenylyl cyclase in the rat striatum vs. the pituitary and other regions of the rat brain.
      K Raynor and T Reisine
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 841-848;

  4. Richelson, E

    1. Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells.
      C Bolden, B Cusack and E Richelson
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 576-580;

  5. Rider, T

    1. Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischemia-reperfusion.
      M R Siegfried, J Erhardt, T Rider, X L Ma and A M Lefer
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 668-675;

  6. Risdahl, J M

    1. Chronic morphine administration impairs cell-mediated immune responses in swine.
      T W Molitor, A Morilla, J M Risdahl, M P Murtaugh, C C Chao and P K Peterson
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 581-586;

  7. Rivera, L M

    1. Demonstration of vasorelaxant activity with an A1-selective adenosine agonist in porcine coronary artery: involvement of potassium channels.
      L A Merkel, R W Lappe, L M Rivera, B F Cox and M H Perrone
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 437-443;

  8. Roehm, N W

    1. Cyclosporine and FK506 inhibition of murine mast cell cytokine production.
      S M Hatfield and N W Roehm
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 680-688;

  9. Rosso, M P

    1. Biochemical and pharmacological activities of SR 26831, a potent and selective elastase inhibitor.
      J M Herbert, D Frehel, M P Rosso, E Seban, C Castet, O Pepin, J P Maffrand and G Le Fur
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 809-816;

S

  1. Saeki, S

    1. Suppression by spinal alpha-2 agonists of motor and autonomic responses evoked by low- and high-intensity thermal stimuli.
      S Saeki and T L Yaksh
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 795-802;

  2. Saito, H

    1. Pharmacological characterization of 5-hydroxytryptamine-induced apnea in the rat.
      M Yoshioka, Y Goda, H Togashi, M Matsumoto and H Saito
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 917-924;

  3. Salonen, I

    1. Effect of chronic ethanol diet on expression of gonadotropin genes in the male rat.
      I Salonen, P Pakarinen and I Huhtaniemi
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 463-467;

  4. Sandberg, J A

    1. Cocaine and metabolite concentrations in the fetal guinea pig after chronic maternal cocaine administration.
      J A Sandberg and G D Olsen
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 587-591;

  5. Sano, T

    1. Pharmacological profile of HS-142-1, a novel nonpeptide atrial natriuretic peptide antagonist of microbial origin. I. Selective inhibition of the actions of natriuretic peptides in anesthetized rats.
      T Sano, Y Morishita, Y Matsuda and K Yamada
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 825-831;

  6. Sawada, Y

    1. Effect of benzylpenicillin on the disposition of cefodizime in rats: no net effect on total clearance due to decreased hepatobiliary clearance and increased renal clearance.
      H Matsushita, H Suzuki, Y Sugiyama, Y Sawada, T Iga, Y Kawaguchi and M Hanano
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 499-504;

  7. Scatton, B

    1. Pharmacological characterization of in vivo [3H]lfenprodil binding sites in the mouse brain.
      J Benavides, B Peny, J Allen and B Scatton
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 896-901;

  8. Schmidt, C J

    1. 5-HT2 receptor antagonists reverse amphetamine-induced slowing of dopaminergic neurons by interfering with stimulated dopamine synthesis.
      S M Sorensen, T M Humphreys, V L Taylor and C J Schmidt
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 872-878;

  9. Schramm, A

    1. Effect of yohimbine on renal sympathetic nerve activity and renal norepinephrine spillover in anesthetized rabbits.
      B Szabo, A Schramm and K Starke
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 780-788;

  10. Schrier, R W

    1. Time-dependent protective effects of calcium channel blockers on anoxia- and hypoxia-induced proximal tubule injury.
      A R Almeida, D Bunnachak, M Burnier, J F Wetzels, T J Burke and R W Schrier
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 526-532;

  11. Schwartz, J A

    1. Renal and antihypertensive effects of a novel eukalemic diuretic, ICI 207,828.
      S T Kau, B B Howe, P A Johnston, J H Li, T J Halterman, J S Zuzack, K Leszczynska, C L Yochim, J A Schwartz and R E Giles
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 450-457;

  12. Seban, E

    1. Biochemical and pharmacological activities of SR 26831, a potent and selective elastase inhibitor.
      J M Herbert, D Frehel, M P Rosso, E Seban, C Castet, O Pepin, J P Maffrand and G Le Fur
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 809-816;

  13. Seth, P

    1. Conversion of nitroglycerin to nitric oxide in microsomes of the bovine coronary artery smooth muscle is not primarily mediated by glutathione-S-transferases.
      S J Chung, S Chong, P Seth, C Y Jung and H L Fung
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 652-659;

  14. Shalaby, I A

    1. Neuroprotective effects of the N-methyl-D-aspartate receptor antagonists ifenprodil and SL-82,0715 on hippocampal cells in culture.
      I A Shalaby, B L Chenard, M A Prochniak and T W Butler
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 925-932;

  15. Sherwin, J R

    1. Botulinum C2 toxin and steroid production in adrenal Y-1 cells: the role of microfilaments in the toxin-induced increase in steroid release.
      R V Considine, L L Simpson and J R Sherwin
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 859-864;

  16. Siegfried, M R

    1. Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischemia-reperfusion.
      M R Siegfried, J Erhardt, T Rider, X L Ma and A M Lefer
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 668-675;

  17. Simpson, L L

    1. Botulinum C2 toxin and steroid production in adrenal Y-1 cells: the role of microfilaments in the toxin-induced increase in steroid release.
      R V Considine, L L Simpson and J R Sherwin
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 859-864;

  18. Slikker, W

    1. The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum.
      J F Bowyer, A W Tank, G D Newport, W Slikker, S F Ali and R R Holson
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 817-824;

  19. Soares-da-Silva, P

    1. Brief transient ischemia induces long-term depletion of norepinephrine without affecting the aromatic amino acid decarboxylase and monoamine oxidase activities in the rat kidney.
      P Soares-da-Silva, M H Fernandes, A Albino-Teixeira, I Azevedo and M Pestana
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 902-908;

  20. Sorensen, S M

    1. 5-HT2 receptor antagonists reverse amphetamine-induced slowing of dopaminergic neurons by interfering with stimulated dopamine synthesis.
      S M Sorensen, T M Humphreys, V L Taylor and C J Schmidt
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 872-878;

  21. Speck, R F

    1. Pharmacokinetics/pharmacodynamics of ketoconazole-prednisolone interaction.
      B Ulrich, F J Frey, R F Speck and B M Frey
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 487-490;

  22. Spuhler, K

    1. Genetic covariation in low alcohol-sensitive and high alcohol-sensitive selected lines of rats: behavioral and electrophysiological sensitivities to the depressant effects of ethanol and the development of acute neuronal tolerance to ethanol in situ at generation eight.
      M R Palmer, J T Harlan and K Spuhler
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 879-886;

  23. Starke, K

    1. Effect of yohimbine on renal sympathetic nerve activity and renal norepinephrine spillover in anesthetized rabbits.
      B Szabo, A Schramm and K Starke
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 780-788;

  24. Stephens, D N

    1. Relief of experimental spasticity and anxiolytic/anticonvulsant actions of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline.
      L Turski, P Jacobsen, T Honoré and D N Stephens
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 742-747;

  25. Sugiyama, Y

    1. Effect of benzylpenicillin on the disposition of cefodizime in rats: no net effect on total clearance due to decreased hepatobiliary clearance and increased renal clearance.
      H Matsushita, H Suzuki, Y Sugiyama, Y Sawada, T Iga, Y Kawaguchi and M Hanano
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 499-504;

  26. Sultana, M

    1. Spinal opioid delta antinociception in the mouse: mediation by a 5'-NTII-sensitive delta receptor subtype.
      A Mattia, S C Farmer, A E Takemori, M Sultana, P S Portoghese, H I Mosberg, W D Bowen and F Porreca
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 518-525;

  27. Suzuki, H

    1. Effect of benzylpenicillin on the disposition of cefodizime in rats: no net effect on total clearance due to decreased hepatobiliary clearance and increased renal clearance.
      H Matsushita, H Suzuki, Y Sugiyama, Y Sawada, T Iga, Y Kawaguchi and M Hanano
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 499-504;

  28. Szabo, B

    1. Effect of yohimbine on renal sympathetic nerve activity and renal norepinephrine spillover in anesthetized rabbits.
      B Szabo, A Schramm and K Starke
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 780-788;

T

  1. Takano, M

    1. H+ coupled active transport of bestatin via the dipeptide transport system in rabbit intestinal brush-border membranes.
      K Inui, Y Tomita, T Katsura, T Okano, M Takano and R Hori
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 482-486;
    2. Blockade of the ATP-sensitive K+ channel by 5-hydroxydecanoate in guinea pig ventricular myocytes.
      T Notsu, I Tanaka, M Takano and A Noma
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 702-708;

  2. Takatani, M

    1. Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents.
      Z Terashita, M Kawamura, M Takatani, S Tsushima, Y Imura and K Nishikawa
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 748-755;

  3. Takemori, A E

    1. Spinal opioid delta antinociception in the mouse: mediation by a 5'-NTII-sensitive delta receptor subtype.
      A Mattia, S C Farmer, A E Takemori, M Sultana, P S Portoghese, H I Mosberg, W D Bowen and F Porreca
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 518-525;

  4. Talaska, G

    1. Hemoglobin adduct and hepatic- and urinary bladder-DNA adduct levels in rapid and slow acetylator Syrian inbred hamsters administered 2-aminofluorene.
      T J Flammang, T Yerokun, M S Bryant, L H Couch, W G Kirlin, K J Lee, F Ogolla, R J Ferguson, G Talaska and D W Hein
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 865-871;

  5. Tanaka, I

    1. Blockade of the ATP-sensitive K+ channel by 5-hydroxydecanoate in guinea pig ventricular myocytes.
      T Notsu, I Tanaka, M Takano and A Noma
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 702-708;

  6. Tank, A W

    1. The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum.
      J F Bowyer, A W Tank, G D Newport, W Slikker, S F Ali and R R Holson
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 817-824;

  7. Tanobe, Y

    1. Mechanism of relaxation induced by K+ and nicotine in dog duodenal longitudinal muscle.
      N Toda, H Baba, Y Tanobe and T Okamura
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 697-701;

  8. Taylor, V L

    1. 5-HT2 receptor antagonists reverse amphetamine-induced slowing of dopaminergic neurons by interfering with stimulated dopamine synthesis.
      S M Sorensen, T M Humphreys, V L Taylor and C J Schmidt
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 872-878;

  9. Terashita, Z

    1. Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents.
      Z Terashita, M Kawamura, M Takatani, S Tsushima, Y Imura and K Nishikawa
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 748-755;

  10. Thériault, G

    1. Age-dependent gentamicin experimental nephrotoxicity.
      D Beauchamp, P Gourde, G Thériault and M G Bergeron
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 444-449;

  11. Thomas, G

    1. Interaction of non-arginine compounds with the endothelium-derived relaxing factor inhibitor, NG-monomethyl L-arginine.
      G Thomas and P W Ramwell
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 676-679;

  12. Toda, N

    1. Mechanism of relaxation induced by K+ and nicotine in dog duodenal longitudinal muscle.
      N Toda, H Baba, Y Tanobe and T Okamura
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 697-701;

  13. Togashi, H

    1. Pharmacological characterization of 5-hydroxytryptamine-induced apnea in the rat.
      M Yoshioka, Y Goda, H Togashi, M Matsumoto and H Saito
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 917-924;

  14. Tokumoto, A

    1. Reduced glomerular hypertrophy by somatostatin analog, SMS 201-995, in the subtotal nephrectomized rats fed high-protein meals.
      J Uemasu, K Godai, A Tokumoto and H Kawasaki
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 505-508;

  15. Tomita, Y

    1. H+ coupled active transport of bestatin via the dipeptide transport system in rabbit intestinal brush-border membranes.
      K Inui, Y Tomita, T Katsura, T Okano, M Takano and R Hori
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 482-486;

  16. Tomlinson, J

    1. Involvement of nitric oxide in nerve-mediated inhibition and action of vasoactive intestinal peptide in colonic smooth muscle.
      J D Huizinga, J Tomlinson and J Pintin-Quezada
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 803-808;

  17. Trachte, G J

    1. Neuromodulatory effects of atrial natriuretic peptides correlate with an inhibition of adenylate cyclase but not an activation of guanylate cyclase.
      J G Drewett, R J Ziegler and G J Trachte
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 689-696;

  18. Trakshel, G M

    1. Tin-protoporphyrin: a potent inhibitor of hemoprotein-dependent steroidogenesis in rat adrenals and testes.
      M D Maines and G M Trakshel
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 909-916;

  19. Tsai, H

    1. Influence of age on control of norepinephrine release from the rat tail artery.
      J Buchholz, H Tsai, D Friedman and S P Duckles
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 722-727;

  20. Tsushima, S

    1. Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents.
      Z Terashita, M Kawamura, M Takatani, S Tsushima, Y Imura and K Nishikawa
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 748-755;

  21. Turski, L

    1. Relief of experimental spasticity and anxiolytic/anticonvulsant actions of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline.
      L Turski, P Jacobsen, T Honoré and D N Stephens
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 742-747;

U

  1. Uemasu, J

    1. Reduced glomerular hypertrophy by somatostatin analog, SMS 201-995, in the subtotal nephrectomized rats fed high-protein meals.
      J Uemasu, K Godai, A Tokumoto and H Kawasaki
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 505-508;

  2. Ulrich, B

    1. Pharmacokinetics/pharmacodynamics of ketoconazole-prednisolone interaction.
      B Ulrich, F J Frey, R F Speck and B M Frey
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 487-490;

  3. Urban, G

    1. Chronic ethanol feeding produces a muscarinic receptor upregulation, but not a muscarinic supersensitivity in lower esophageal sphincter muscle.
      A Keshavarzian, J H Gordon, C Willson, G Urban and J Z Fields
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 601-607;

V

  1. Vargaftig, B B

    1. Thromboxane A2 accounts for bronchoconstriction but not for platelet sequestration and microvascular albumin exchanges induced by fMLP in the guinea pig lung.
      M F Bureau, F De Clerck, J Lefort, C D Arreto and B B Vargaftig
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 832-840;

  2. Verley, J

    1. Histamine receptors on human isolated pulmonary arterial muscle preparations: effects of endothelial cell removal and nitric oxide inhibitors.
      J L Ortiz, C Labat, X Norel, I Gorenne, J Verley and C Brink
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 762-767;

W

  1. Weissman, B A

    1. Antagonism studies with BMY-7378 and NAN-190: effects on 8-hydroxy-2-(di-n-propylamino)tetralin-induced increases in punished responding of pigeons.
      S T Ahlers, B A Weissman and J E Barrett
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 474-481;

  2. Wetzels, J F

    1. Time-dependent protective effects of calcium channel blockers on anoxia- and hypoxia-induced proximal tubule injury.
      A R Almeida, D Bunnachak, M Burnier, J F Wetzels, T J Burke and R W Schrier
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 526-532;

  3. Willson, C

    1. Chronic ethanol feeding produces a muscarinic receptor upregulation, but not a muscarinic supersensitivity in lower esophageal sphincter muscle.
      A Keshavarzian, J H Gordon, C Willson, G Urban and J Z Fields
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 601-607;

  4. Wolff, D W

    1. Subtype-selective alpha-1 adrenoceptor alkylation in the rat kidney and its effect on the vascular pressor response.
      A M Elhawary, W A Pettinger and D W Wolff
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 709-713;

  5. Wong, W S

    1. Pharmacologic evaluation of A23187-induced contractions of three distinct preparations of guinea pig lung parenchymal strips.
      W S Wong, A M Bendele and J H Fleisch
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 714-721;

Y

  1. Yaksh, T L

    1. Suppression by spinal alpha-2 agonists of motor and autonomic responses evoked by low- and high-intensity thermal stimuli.
      S Saeki and T L Yaksh
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 795-802;

  2. Yamada, K

    1. Pharmacological profile of HS-142-1, a novel nonpeptide atrial natriuretic peptide antagonist of microbial origin. I. Selective inhibition of the actions of natriuretic peptides in anesthetized rats.
      T Sano, Y Morishita, Y Matsuda and K Yamada
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 825-831;

  3. Yan, Q S

    1. Effects of fluoxetine on convulsions and on brain serotonin as detected by microdialysis in genetically epilepsy-prone rats.
      J W Dailey, Q S Yan, P K Mishra, R L Burger and P C Jobe
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 533-540;

  4. Yerokun, T

    1. Hemoglobin adduct and hepatic- and urinary bladder-DNA adduct levels in rapid and slow acetylator Syrian inbred hamsters administered 2-aminofluorene.
      T J Flammang, T Yerokun, M S Bryant, L H Couch, W G Kirlin, K J Lee, F Ogolla, R J Ferguson, G Talaska and D W Hein
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 865-871;

  5. Yochim, C L

    1. Renal and antihypertensive effects of a novel eukalemic diuretic, ICI 207,828.
      S T Kau, B B Howe, P A Johnston, J H Li, T J Halterman, J S Zuzack, K Leszczynska, C L Yochim, J A Schwartz and R E Giles
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 450-457;

  6. Yokotani, K

    1. Release of endogenous noradrenaline from the vascularly perfused rat stomach in vitro: modulation by pre- and postsynaptic adrenoceptors.
      K Yokotani, Y Okuma and Y Osumi
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 728-733;

  7. Yoshioka, M

    1. Pharmacological characterization of 5-hydroxytryptamine-induced apnea in the rat.
      M Yoshioka, Y Goda, H Togashi, M Matsumoto and H Saito
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 917-924;

Z

  1. Zbaida, S

    1. Role of electronic factors in binding and reduction of azo dyes by hepatic microsomes.
      S Zbaida and W G Levine
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 554-561;

  2. Ziegler, R J

    1. Neuromodulatory effects of atrial natriuretic peptides correlate with an inhibition of adenylate cyclase but not an activation of guanylate cyclase.
      J G Drewett, R J Ziegler and G J Trachte
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 689-696;

  3. Zuzack, J S

    1. Renal and antihypertensive effects of a novel eukalemic diuretic, ICI 207,828.
      S T Kau, B B Howe, P A Johnston, J H Li, T J Halterman, J S Zuzack, K Leszczynska, C L Yochim, J A Schwartz and R E Giles
      Journal of Pharmacology and Experimental Therapeutics February 1992, 260 (2) 450-457;
Back to top

In this issue

Advertisement